|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar
|
|
2
|
Davis FG and McCarthy BJ: Current
epidemiological trends and surveillance issues in brain tumors.
Expert Rev Anticancer Ther. 1:395–401. 2001. View Article : Google Scholar
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu JJ, Gao GZ and Zhang SM: miR-218
inhibits the migration and invasion of glioma U87 cells through the
Slit2-Robo1 pathway. Oncol Lett. 9:1561–1566. 2015.PubMed/NCBI
|
|
5
|
Caruso C, Carcaterra M and Donato V: Role
of radiotherapy for high grade gliomas management. J Neurosurg Sci.
57:163–169. 2013.PubMed/NCBI
|
|
6
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang BC and Ma J: Role of microRNAs in
malignant glioma. Chin Med J (Engl). 128:1238–1244. 2015.
View Article : Google Scholar
|
|
9
|
Wang LG, Ni Y, Su BH, Mu XR, Shen HC and
Du JJ: MicroRNA-34b functions as a tumor suppressor and acts as a
nodal point in the feedback loop with Met. Int J Oncol. 42:957–962.
2013.PubMed/NCBI
|
|
10
|
Shen J, Niu W, Zhou M and Zhang H, Ma J,
Wang L and Zhang H: MicroRNA-410 suppresses migration and invasion
by targeting MDM2 in gastric cancer. PLoS One. 9:e1045102014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuhn AR, Schlauch K, Lao R, Halayko AJ,
Gerthoffer WT and Singer CA: MicroRNA expression in human airway
smooth muscle cells: Role of miR-25 in regulation of airway smooth
muscle phenotype. Am J Respir Cell Mol Biol. 42:506–513. 2010.
View Article : Google Scholar :
|
|
12
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
96(Suppl): R40–R44. 2007.PubMed/NCBI
|
|
13
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Zhang J, Wu J, Luo D, Su K, Shi W,
Liu J, Tian Y and Wei L: MicroRNA-610 inhibits the migration and
invasion of gastric cancer cells by suppressing the expression of
vasodilator-stimulated phosphoprotein. Eur J Cancer. 48:1904–1913.
2012. View Article : Google Scholar
|
|
16
|
Zeng XC, Liu FQ, Yan R, Yi HM, Zhang T,
Wang GY, Li Y and Jiang N: Downregulation of miR-610 promotes
proliferation and tumorigenicity and activates Wnt/β-catenin
signaling in human hepatocellular carcinoma. Mol Cancer.
13:2612014. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
18
|
Ichimi T, Enokida H, Okuno Y, Kunimoto R,
Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama
K, et al: Identification of novel microRNA targets based on
microRNA signatures in bladder cancer. Int J Cancer. 125:345–352.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB,
Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL,
Andersen CL, Zieger K, et al: Genomic profiling of microRNAs in
bladder cancer: miR-129 is associated with poor outcome and
promotes cell death in vitro. Cancer Res. 69:4851–4860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu XP, Mou KJ, Xu QF, Tang JH, Huang GH,
Xu JP, Li GH, Ai SJ, Hugnot JP, Zhou Z and Lv SQ: Microarray
analysis of the aberrant microRNA expression pattern in gliomas of
different grades. Oncol Rep. 34:318–324. 2015.PubMed/NCBI
|
|
21
|
Xu D, Ma P, Gao G, Gui Y, Niu X and Jin B:
MicroRNA-383 expression regulates proliferation, migration,
invasion, and apoptosis in human glioma cells. Tumour Biol.
36:7743–7753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun JY, Xiao WZ, Wang F, Wang YQ, Zhu YH,
Wu YF, Miao ZL and Lin YC: MicroRNA-320 inhibits cell proliferation
in glioma by targeting E2F1. Mol Med Rep. 12:2355–2359.
2015.PubMed/NCBI
|
|
23
|
Nakayama T, Toguchida J, Wadayama B, Kanoe
H, Kotoura Y and Sasaki MS: MDM2 gene amplification in bone and
soft-tissue tumors: Association with tumor progression in
differentiated adipose-tissue tumors. Int J Cancer. 64:342–346.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haines DS, Landers JE, Engle LJ and George
DL: Physical and functional interaction between wild-type p53 and
mdm2 proteins. Mol Cell Biol. 14:1171–1178. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Momand J, Wu HH and Dasgupta G: MDM2 -
master regulator of the p53 tumor suppressor protein. Gene.
242:15–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Momand J, Jung D, Wilczynski S and Niland
J: The MDM2 gene amplification database. Nucleic Acids Res.
26:3453–3459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Finlay CA: The mdm-2 oncogene can overcome
wild-type p53 suppression of transformed cell growth. Mol Cell
Biol. 13:301–306. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leach FS, Tokino T, Meltzer P, Burrell M,
Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW and Vogelstein
B: p53 Mutation and MDM2 amplification in human soft tissue
sarcomas. Cancer Res. 53:2231–2234. 1993.PubMed/NCBI
|
|
29
|
Oliner JD, Kinzler KW, Meltzer PS, George
DL and Vogelstein B: Amplification of a gene encoding a
p53-associated protein in human sarcomas. Nature. 358:80–83. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang AL, Liu ZX, Li G and Zhang LW:
Expression and significance of P53 protein and MDM-2 protein in
human gliomas. Chin Med J (Engl). 124:2530–2533. 2011.
|
